Insights from Flagship Biosciences’ team of multidisciplinary experts.
Share this Post: It is no secret that drug developers are under increasing pressure to discover new targeted therapies to meet high unmet medical needs,
The “One Number” Promise: Insights from the Next Generation Dx Summit Highlight the Need for Integrated, Unified and Actionable Data
Share this Post: Twenty years ago, the foundation for Next-Gen Sequencing was set. Ten years ago, advances made NGS a viable platform. Today, clinicians are
Share this Post: In an important first, the FDA recently granted accelerated approval to Keytruda® for an indication that is based on a common biomarker
Back to Blog Share this Post: On April 12, 2017, FDA granted marketing clearance for the Philips IntelliSite Pathology Solution (PIPS), the first Whole Slide
Combining Genomic Profiling and Tissue-Based Biomarker Assays to Aid in the Early Detection and Prevention of Cancer
Back to Blog Share this Post: Genomic sequencing of precancerous lesions to improve prevention and early detection of cancer was a major focus at the